Temperature-sensitive Ovarian Carcinoma Cell Line (OvBH-1)

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Tumor Cells

Tissue Type

Ovary

Organism

Human (H. sapiens)

Donor History

Female

,

49

,

Caucasian

,

Adenocarcinoma

Growth Properties

Adherent

,

epithelial

Growth Conditions

PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. Prigrow VIII Medium (TM018) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂. 

Immortalization Method

Tumor Cell Line

Full Information

https://www.abmgood.com/Temperature-sensitive-Ovarian-Carcinoma-Cell-Line-OvBH-1-T8163.html

Katalogové číslo: T8163 Kategorie: ,
Popis

Cells were isolated from an ascitic fluid patient with an ovarian tumor histopathologically classified as ovarian clear cell adenocarcinoma, poorly differentiated (G3) and in stage FIGO IV. OvBH-1 cell showed expression of cytokeratins (CK): CK1,5,6,8,10,14,18,7,16/18, alongside vimentin, tumor-associated antigens (CA125, OV-TL3), p53 protein, c-rebB-2 oncoprotein detected by IHC. Sequencing of all coding exons of TP53 gene showed a natural genetic polymorphism namely a G-to-A substitution at nucleotide 13 432 GAG to GAA, corresponding to codon 2233 in exon 6.OvBH-1 cells are notable for their cytomorphological diversity and present two morphologically distinct cell types. The dominant cell type within the OVBH-1 line appears to have frank malignancy features, suggesting a more aggressive cancer phenotype. The epithelial origin of both cell types is confirmed by immunophenotypic staining using antibodies against different cytokeratins. The expression of tumor-associated antigens (CA125, OP-TL3) was found in both cell subtypes, reaffirming their origin from ovarian carcinoma. The OvBH-1 cell line has temperature-sensitive properties. This cell line is suitable for investigating the biological changes that contribute to carcinogenesis and chemoresistance.

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.